Independent project, not run by or affiliated with Hammersmith & Fulham Council
AXIOM MEDICAL LTD
Company. Hammersmith & Fulham Council paid it £50,000 in 12 payments in the council’s files from July 2024 to April 2025, excluding VAT.
The name is as the council wrote it.
On the companies register
- Registered as
- AXIOM MEDICAL LTD, company number 06989729
- Status
- Active
- Type
- Private limited company, formed August 2009
- What it does
- Research and experimental development on biotechnology; General medical practice activities
- Registered office
- In Barnet
Linked because the council's name for it is exactly this company's name, and the company existed before the council first paid it. From Companies House, Free Company Data Product (basic company data, live companies), 1 Oct 2026. What it does is the company’s own description to Companies House.
By service
By month
Months with no payment to AXIOM MEDICAL LTD are left out. Pick a month to see every payment the council made that month.
Largest payments
| Date | Service | What for | Amount |
|---|---|---|---|
| 10 Jul 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 10 Jul 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 10 Jul 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 19 Aug 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 9 Sept 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 11 Oct 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 4 Nov 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 10 Dec 2024 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 2 Jan 2025 | Public health | Payments to Voluntary Bodies | £4,166.67 |
| 4 Feb 2025 | Public health | Payments to Voluntary Bodies | £4,166.67 |
sourcedAmounts: the council's own figures, excluding VATsourcedServices: matched from the council's service areas and checked by hand
From 4 of the council's spend files: Spend data Q2 2024-25, Spend data Q3 2024-25, Spend data Q4 2024-25, Spend data Q1 2025-26.